Holen Sie sich die Stockscreener-App
26.76
1.04%
-0.267
Schlusskurs vom Vortag:
$27.03
Offen:
$26.62
24-Stunden-Volumen:
143.71K
Relative Volume:
0.19
Marktkapitalisierung:
$2.18B
Einnahmen:
$1.93B
Nettoeinkommen (Verlust:
$174.22M
KGV:
13.04
EPS:
2.0516
Netto-Cashflow:
$237.32M
1W Leistung:
+1.06%
1M Leistung:
-1.22%
6M Leistung:
+35.44%
1J Leistung:
+57.82%
1-Tages-Spanne:
$26.28
$26.85
1-Wochen-Bereich:
$26.28
$27.28
52-Wochen-Spanne:
$15.70
$27.94
Pediatrix Medical Group Inc Stock (MD) Company Profile
Firmenname
Pediatrix Medical Group Inc
Sektor
Branche
Telefon
(954) 384-0175
Adresse
1301 CONCORD TERRACE, SUNRISE, FL
Compare MD vs HCA, THC, FMS, EHC, DVA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MD
Pediatrix Medical Group Inc
|
26.78 | 2.20B | 1.93B | 174.22M | 237.32M | 2.0516 |
HCA
Hca Healthcare Inc
|
400.43 | 87.68B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
259.39 | 21.34B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
22.47 | 12.06B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
120.55 | 12.01B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
182.48 | 11.74B | 13.84B | 1.10B | 1.49B | 10.42 |
Pediatrix Medical Group Inc Stock (MD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-09-26 | Hochstufung | Jefferies | Hold → Buy |
| 2024-06-07 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-06-23 | Fortgesetzt | Stifel | Hold |
| 2020-10-19 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2020-01-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-12-12 | Hochstufung | Stifel | Hold → Buy |
| 2019-09-06 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-01-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-09-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-09-18 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2018-08-03 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-07-12 | Eingeleitet | Leerink Partners | Mkt Perform |
| 2018-03-27 | Eingeleitet | Credit Suisse | Neutral |
| 2018-02-12 | Bestätigt | Mizuho | Neutral |
| 2017-12-13 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-09-18 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2017-05-30 | Bestätigt | Mizuho | Neutral |
| 2017-05-25 | Bestätigt | Stifel | Hold |
| 2017-05-04 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2017-03-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2017-03-10 | Herabstufung | JP Morgan | Overweight → Neutral |
Alle ansehen
Pediatrix Medical Group Inc Aktie (MD) Neueste Nachrichten
Cencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue? - Zacks Investment Research
Vanguard confirms over 7% Pediatrix (NYSE: MD) stake, no change reported - Stock Titan
One holder owns 5.15% of Pediatrix (NYSE: MD). The latest filing corrects details, not the stake. - Stock Titan
Vanguard Group now shows no Pediatrix (NYSE: MD) stake - Stock Titan
Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Better‑Than‑Expected Q2 Revenue and Reiterated EBITDA Guidance Could Be A Game Changer For Pediatrix Medical Group (MD) - webull.com
Pediatrix Medical Group stock rises on $0.63 EPS - AD HOC NEWS
Pediatrix Medical Group stock holds near $26.23 - AD HOC NEWS
Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy? - Eastern Progress
Pediatrix Medical Group (MD) Soars 7.3%: Is Further Upside Left in the Stock? - Eastern Progress
Q2 Earnings Highlights: Pediatrix Medical Group (NYSE:MD) Vs The Rest Of The Healthcare Providers & Services Stocks - Yahoo Finance
Pediatrix Medical Group (MD) Faces Demand Questions, Is The Recent Rally Already Priced In? - sahmcapital.com
Zacks Research Has Positive Estimate for MD FY2026 Earnings - MarketBeat
Pediatrix (MD) EPS and Revenue: EPS Exceeds Its Estimate at the Close; Stock Move: Shares Show Limited Movement in the Latest SessionCash Flow Report - vinanet.vn
Pediatrix (MD) Results at a Glance: Reported EPS Tops Expectations in the Latest Reading; Stock Move: Shares Close 1.03% Higher for the Current SessionProfit Warning Alert - vinanet.vn
What is Zacks Research's Forecast for MD Q1 Earnings? - MarketBeat
Pediatrix (MD) Earnings Snapshot: The Available Earnings Metric Delivers a Beat at the Close; Closing Move: Shares Finish 1.28% Down in the Latest SessionEarnings Sentiment Score - vinanet.vn
Pediatrix (MD) Momentum: Loses 1.28% to Close at $26.22 in the Current Update; Next Session - vinanet.vn
This Baidu Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday - Benzinga
PEDIATRIX MEDICAL GROUP INC : JEFFERIES CUTS TO HOLD FROM BUY; RAISES TARGET PRICE TO $28 FROM $27 - Bitget
Why is Pediatrix Medical stock slipping today? By Investing.com - Investing.com Canada
ETFs Investing in Pediatrix Medical Group, Inc. Stocks - TradingView
Pediatrix (MD) Results Review: EPS Lands Above Forecast in the Latest Reading; Closing Move: Shares Finish 0.84% HigherEarnings Deceleration Risk - vinanet.vn
Jefferies downgrades Pediatrix Medical stock rating on valuation By Investing.com - Investing.com South Africa
Pediatrix (MD) Trading-Day Recap: Ends Higher by 0.84% at $26.56 on the Day; Level Position: Support at $25.23 and Resistance at $27.89 Frame the RangeReversal Trade - vinanet.vn
Pediatrix Medical Group (MD) Slips 1.5% as Shares Test Key Technical LevelsMFI Divergence - vinanet.vn
Will Earnings Beat and Major Buybacks Change Pediatrix Medical Group's (MD) Narrative - simplywall.st
Pediatrix Medical Group (MD) Edges Up 0.91% to $26.61, Holds Above Key SupportBuffered ETF - vinanet.vn
Pediatrix Medical Group (NYSE:MD): A Value Stock with a Clear Margin of Safety - ChartMill
Pediatrix Medical Group, Inc. SEC Filing (Aug 14, 2026) - Stock Titan
Pediatrix Medical Group (MD) director awarded 472 restricted shares and reports trust holdings - Stock Titan
Pediatrix Medical Group (MD) director receives 472 restricted shares in equity grant - Stock Titan
Pediatrix Medical Group (MD) director receives 472-share restricted stock grant - Stock Titan
Pediatrix Medical Group (MD) grants 472 restricted shares to director Sansone - Stock Titan
Pediatrix Medical Group (MD) director gets 472-share equity grant - Stock Titan
Pediatrix Medical Group (MD) director awarded 472 restricted shares in equity grant - Stock Titan
Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio - Zacks Investment Research
Pediatrix Medical Group, Inc. Stock 12‑Month Price Target Cut to $26, Implies 2% Downside - TradingView
5 Must-Read Analyst Questions From Pediatrix Medical Group’s Q2 Earnings Call - Yahoo Finance
Pediatrix Medical Group, Inc. (MD) Stock Forecasts - Yahoo Finance
Wasatch Advisors LP Boosts Stake in Pediatrix Medical Group, Inc. $MD - MarketBeat
Pediatrix Medical Group (MD) Q2 2026 Earnings Call Transcript - AOL.com
Pediatrix Medical Group, Inc. (MD) Stock Analysis: Understanding the Healthcare Stock’s Growth Potential and Analyst Ratings - DirectorsTalk Interviews
Pediatrix Medical Group (MD) Falls 3.69% to $26.08, Approaching Key Support at $24.78Double Bottom - vinanet.vn
Pediatrix Medical Group (MD) Earnings Growth Puts Its Valuation Back In Focus - Yahoo Finance
Is Stronger Q2 2026 EPS From Operations Altering The Investment Case For Pediatrix Medical Group (MD)? - Yahoo Finance
Does Pediatrix’s Modest Profit Uptick Reveal a Deeper Shift in MD’s Efficiency Story? - simplywall.st
Sei Investments Co. Cuts Stock Holdings in Pediatrix Medical Group, Inc. $MD - MarketBeat
Pediatrix Medical Tops Q2 Earnings on Better Cash Collections - Zacks Investment Research
UBS Adjusts Price Target on Pediatrix Medical to $28 From $25, Maintains Neutral Rating - marketscreener.com
Full Transcript: Pediatrix Medical Group Q2 2026 Earnings Call - Sahm
Finanzdaten der Pediatrix Medical Group Inc-Aktie (MD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.26%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):